John L Isler, MD | |
160 Boston Avenue, Atlanta Springs, FL 32701-4798 | |
(407) 834-7776 | |
(407) 834-0973 |
Full Name | John L Isler |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 160 Boston Avenue, Atlanta Springs, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013918614 | NPI | - | NPPES |
037931000 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | ME0033843 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
John L Isler, MD 160 Boston Avenue, Altamonte Springs, FL 32701-4798 Ph: (407) 834-7776 | John L Isler, MD 160 Boston Avenue, Atlanta Springs, FL 32701-4798 Ph: (407) 834-7776 |
News Archive
Metastasis, the process in which a tumor spreads to other parts of the body, is responsible for 90% of deaths from tumors. It is the greatest challenge to a cancer patient's survival. Metastatic spread occurs in several steps, these include that tumor cells become mobile and cross into and out of blood vessels.
These days, many people are concerned about plastic waste; however, the convenience, mechanical properties and cost of plastic food packaging are hard to beat.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health to initiate a Phase IIa clinical study evaluating the safety and efficacy of sustained erythropoietin therapy produced and delivered by the Company's EPODURE Biopumps.
A new national study published in Psychiatric Services finds that over a quarter of US adults with depression or anxiety symptoms reported needing mental health counseling but were not able to access it during the COVID-19 pandemic.
Viking Systems, Inc. today announced financial results for its first quarter ended March 31, 2010. The Company reported a 26% increase in sales to $1,915,073 for the quarter ended March 31, 2010 and a net loss of $295,450 or ($0.01) per share.
› Verified 9 days ago